User menu

Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22?

Bibliographic reference Elens, Laure ; Haufroid, Vincent. Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22?. In: Pharmacogenomics, Vol. 18, p. 1473-1480 (2017)
Permanent URL
  1. Elens Laure, van Gelder Teun, Hesselink Dennis A, Haufroid Vincent, van Schaik Ron HN, CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy, 10.2217/pgs.12.187
  2. Haufroid V., Wallemacq P., VanKerckhove V., Elens L., De Meyer M., Eddour D. C., Malaise J., Lison D., Mourad M., CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study, 10.1111/j.1600-6143.2006.01518.x
  3. Hesselink Dennis A., Bouamar Rachida, Elens Laure, van Schaik Ron H. N., van Gelder Teun, The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation, 10.1007/s40262-013-0120-3
  4. Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik RHN, Thummel KE, Klein TE, Caudle KE, MacPhee IAM, Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing, 10.1002/cpt.113
  5. Andreu Franc, Colom Helena, Elens Laure, van Gelder Teun, van Schaik Ronald H. N., Hesselink Dennis A., Bestard Oriol, Torras Joan, Cruzado Josep M., Grinyó Josep M., Lloberas Nuria, A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach, 10.1007/s40262-016-0491-3
  6. Elens Laure, Capron Arnaud, van Schaik Ron HN, De Meyer Martine, De Pauw Luc, Eddour Djamila C., Latinne Dominique, Wallemacq Pierre, Mourad Michel, Haufroid Vincent, Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation : Toward Updated Genotype-Based Dosage Guidelines, 10.1097/ftd.0b013e318296045b
  7. Elens Laure, Hesselink Dennis A., van Schaik Ron H. N., van Gelder Teun, TheCYP3A4*22allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations : Letter to the Editors, 10.1111/bcp.12038
  8. Elens Laure, van Schaik Ron H, Panin Nadtha, de Meyer Martine, Wallemacq Pierre, Lison Dominique, Mourad Michel, Haufroid Vincent, Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients, 10.2217/pgs.11.90
  9. Wang D, Guo Y, Wrighton S A, Cooke G E, Sadee W, Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs, 10.1038/tpj.2010.28
  10. Wang Danxin, Sadee Wolfgang, CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing : , 10.1097/fpc.0000000000000183
  11. Woillard Jean-Baptiste, Mourad Michel, Neely Michael, Capron Arnaud, van Schaik Ron H., van Gelder Teun, Lloberas Nuria, Hesselink Dennis A., Marquet Pierre, Haufroid Vincent, Elens Laure, Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation, 10.3389/fphar.2017.00358
  12. De Meyer Martine, Haufroid Vincent, Kanaan Nada, Darius Tom, Buemi Antoine, De Pauw Luc, Eddour Djamila Chaïb, Wallemacq Pierre, Mourad Michel, Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study, 10.2217/pgs-2016-0005
  13. Capron Arnaud, Mourad Michel, De Meyer Martine, De Pauw Luc, Eddour Djamila Chaib, Latinne Dominique, Elens Laure, Haufroid Vincent, Wallemacq Pierre, CYP3A5andABCB1polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation, 10.2217/pgs.10.43
  14. de Jonge Hylke, Metalidis Christoph, Naesens Maarten, Lambrechts Diether, Kuypers Dirk RJ, The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients, 10.2217/pgs.11.77
  15. Elens Laure, Hesselink Dennis A., Bouamar Rachida, Budde Klemens, de Fijter Johannes W., De Meyer Martine, Mourad Michel, Kuypers Dirk R. J., Haufroid Vincent, van Gelder Teun, van Schaik Ron H. N., Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine a in Renal Transplant Patients : , 10.1097/ftd.0b013e31829da6dd